Dr. Priya P. Gor, MD

Dr. Gor practices at Virtua Voorhees Hospital in Voorhees, New Jersey, part of Virtua Health.

Dr. Gor's NPI, 1710915269, was assigned on June 30, 2006. Dr. Gor graduated from Rutgers Robert Wood Johnson Medical School in 2000. Dr. Gor's New Jersey license number on file is 25MA08201600.

Dr. Gor's primary practice is Virtua Voorhees Hospital, at 100 Bowman Drive, Voorhees, NJ 08043 in Camden County. The practice phone is (856) 247-3000.

Dr. Gor's primary practice is Virtua Voorhees Hospital in Voorhees, New Jersey, part of Virtua Health. Dr. Gor is also affiliated with Cooper University Hospital. The medical group on file is Penn Heart and Vascular Center Cherry Hill. Dmand AI also links Dr. Gor to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gor practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Gor's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Gor is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Gor's licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer and lung cancer among the conditions Dr. Gor treats.

CMS data shows 12,636 Medicare services from Dr. Gor across 34 procedure codes in 2024, for 515 Medicare patients. Medicare paid $169,897 for them.

CMS counts 515 Medicare patients who saw Dr. Gor in 2024. The largest group is 65 to 74, with 253 patients. 75% of them have cancer, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gor's median patient age at 66, with 91% women.

In 2024, Dr. Gor wrote 993 Medicare Part D claims for 300 patients. 90% of them were for generic drugs. CMS names the drug for 875 of them, across 16 drugs with 11 or more claims each, at $1,252,096 in total drug cost. In 2023, CMS named 1,152 claims across 18 drugs.

Dr. Gor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gor as offering telehealth.

Dmand AI links 2 papers to Dr. Gor, published from 2010 to 2024. The most frequent topics are Biomarkers, Tumor and Breast Neoplasms. Dr. Gor's most frequent co-authors are Richard Aplenc, MD, Steven Mark Sorscher, MD and Martin S. Tallman, MD.

Dmand AI links Dr. Gor to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Breast Neoplasms and Breast Diseases. Novartis Pharmaceuticals sponsors the most, 2.

CMS Open Payments shows 16 general payments to Dr. Gor from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Pfizer Inc. paid the most, $131.

Dr. Gor graduated from Rutgers Robert Wood Johnson Medical School in 2000.

Dr. Gor is in network with 19 carriers, including Elevance, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.